Facebook
Twitter
LinkedIn
ForwardTitle
Category
Credits
Event date
Cost
- Research to Practice
- 1.00 Participation
$0.00
Shetal Patel, MD, PhD, from the UNC Lineberger Thoracic Oncology group will describe relevant updates in systemic therapy for lung cancers for health care providers throughout the state of North Carolina. Additional topical management considerations or recommendations for this patient population may also be presented.
- Research to Practice
- 1.00 Participation
$0.00
Dr. Trevor Royce from the UNC Lineberger Department of Radiation Oncology will describe relevant updates in radiation oncology for health care providers throughout the state of North Carolina. With a focus on bladder cancer—highlights will include updates on techniques and indications for radiotherapy, toxicity monitoring, recent research, and other issues.
- Research to Practice
- 1.00 Participation
$0.00
Oral chemotherapy is becoming increasingly common in treatment of various malignancies. Although oral oncolytics are extremely beneficial for patients, they also present unique challenges for patients and providers alike. Implementing oral chemotherapy often requires a multidisciplinary approach. This lecture discusses several considerations for oral chemotherapy such as prescribing, patient education, adherence, medication access, cost and insurance authorization, monitoring, supportive care, and more. We will walk through a patient case to highlight practical suggestions for successful implementation of oral chemotherapy for patients.
- Research to Practice
- 1.00 Participation
$0.00
Arthur Blackstock, Jr., MD, will discuss protons entering the state, the expanded use of Stereotactic Body Radiation Therapy (SBRT), and perhaps review the impact of PSMA imaging in Radiation Oncology.
- Research to Practice
- 1.00 Participation
$0.00
Jose Gaston Guillem, MD, MPH, MBA, will describe how at UNC Medical Center a team of experts carefully reviews each individual patient during a Weekly GI Tumor Board and collaboratively develop a treatment plan which defines the specific timing and sequence of care for each patient.
- Research to Practice
- 1.00 Participation
$0.00
This lecture will review some of the new drugs recently FDA approved for management of lymphoma such as CAR-T therapy for relapsed/refractory Mantle Cell Lymphoma or follicular lymphoma. For rel/ref DLBCL, polatuzumab vedotin in combination with bendamustine and rituximab as well as tafasitamab plus lenalidomide have been approved in recent years. We will review the data and outcomes.
- Research to Practice
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ODS
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Jethro Hu, MD, will review the rationale and current evidence supporting the potential role of a ketogenic diet for brain tumor patients, focusing on a recently completed phase 1 safety and feasibility trial.
- Research to Practice
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.25 ASRT
- 1.00 ODS
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Michael Galgano, MD, FAANS, will focus on differentiating the various types of spinal tumors, ranging from metastases, to primary vertebral column tumors, and intradural spinal cord tumors. He will discus the contributions of co-morbidities and frailty on the management of patients with spinal tumors. He will also aim to give the audience a brief exposure to the surgical management of spinal oncology, and what is entailed to execute robust local control.
- Research to Practice
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.25 ASRT
- 1.00 ODS
- 1.25 NCPD/CNE
- 1.00 Participation
$0.00
Anne W. Beaven, MD, will review recent updates and evolving standard of care for management of Hodgkin and Non-Hodgkin lymphoma.
- Research to Practice
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.50 ASRT
- 1.00 ODS
- 1.00 Participation
$0.00
Breast cancer management continues to evolve with tailored therapies allowing for a personalized approach to treatment. This is an update on current surgical considerations for breast cancer management.